Latest Breaking News On - Cancer research network - Page 1 : comparemela.com

Major Contributors to Cancer Research and Treatment

Major Contributors to Cancer Research and Treatment
bignewsnetwork.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bignewsnetwork.com Daily Mail and Mail on Sunday newspapers.

United statesSusang komenLaurence belferSidney kimmelRobert belferMary claire kingRenee belferNational cancer instituteSusang komen foundationKimmel cancer centerBelfer centerWorld health organizationUs national institutes of healthRenee belfer centerCancer research networkDana farber cancer institute

Expanding clinical trial diversity requires showing up in the community to build trust

Expanding clinical trial diversity requires showing up in the community to build trust
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

United statesLucyj gansauerNicole richieAnna eshooMindy valcarcelGenentech rocheEdwards kimKristi mitchellByjosh friedmanCity of hope national medical centerFriends of cancer researchAtlas clarityCancer research networkHealth equity outcomesCancer researchHemonc today

The Side Effect Roulette of Cancer Treatment

The Side Effect Roulette of Cancer Treatment
goodmenproject.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from goodmenproject.com Daily Mail and Mail on Sunday newspapers.

United statesNew jerseyJoseph ungerMichelle tregearEli lillyTracy henriksonBishal gyawaliDonald sullivanDevin peipertLauren jei mccarthyHillary andrewsBridgette obrienHealth newsDrug administrationWashington postTerms of service

Combination of dasatinib and blinatumomab offers effective treatment for older Ph+ ALL patients

Older patients with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) who were not good candidates for the standard treatment of intensive chemotherapy had a median overall survival (OS) of 6.5 years on an alternate regimen of dasatinib and blinatumomab.

United statesBrentl woodSusanm obrienAnjalis advaniAaront gerdsJeraldp radichMark litzowJanel liesveldMatthew wieduwiltAnna moseleyHarryp erbaLos angelesDeepa jeyakumarGeorge yaghmourCeciliacs yeungKristen odwyer

Long-term results show combination treatment that skips chemotherapy is effective for older patients with Ph+ ALL

Long-term results show combination treatment that skips chemotherapy is effective for older patients with Ph+ ALL
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

United statesKristen odwyerAnjalis advaniWilmot cancer instituteCancer research networkAmerican society of hematologyUniversity of rochesterCleveland clinic cancer instituteAmerican societyAnnual meetingSan diegoKristeno dwyerResearch networkOlder patientsPositive acute lymphoblastic leukemiaLymphoblastic leukemias